Immunomodulation in Human Dendritic Cells Leads to Induction of Interferon-gamma Production by Leishmania Donovani Derived KMP-11 Antigen Via Activation of NF-κB in Indian Kala-azar Patients
Overview
Biotechnology
General Medicine
Authors
Affiliations
Dendritic cells (DCs) and macrophages (MΦs) are well-known antigen presenting cells with an ability to produce IL-12 which indicates that they have potential of directing acquired immunity toward a Th1-biased response. The aim of this study was to examine the effect of Leishmania specific KMP-11 antigen through comparison of immune responses after presentation by DCs and MΦs to T cells in Indian patients with VL. Patients with DCS and MΦs were directed against a purified Leishmania donovani antigen (KMP-11) and phytohaemagglutinin (PHA). The cytokines (IL-12, IL-10, and TGF-β) producing abilities of the DCs and MΦs against these antigens were determined by flow cytometry. The transcription factor (NF-κB) and T-cell cytokine support (IFN-γ, IL-10), which could be significant in effector immune function, were also determined. Severe hindrance in the immune protection due to Leishmania parasites, as revealed by decreased expression of IL-12 and upregulation of IL-10 and TGF-β expression in the MΦs compared to DCs, occurred in VL patients. The production of IL-12 in response to L. donovani KMP-11 antigen was increased in DCs which was reduced in MΦs of VL patients. In contrast, the presentation of KMP-11 antigen by DCs to T-lymphocytes in VL patients significantly increased the IFN-γ produced by these immune cells, whereas the levels of IL-10 were significantly elevated after presentation of KMP-11 antigen by MΦs. The VL patients were observed with severely dysfunctional MΦs in terms of NF-κB activity that could be recovered only after stimulation of DCs with L. donovani KMP-11 antigen. Immunologically the better competitiveness of KMP-11 antigen through a dendritic cell delivery system may be used to revert T-cell anergy, and control strategy can be designed accordingly against kala-azar.
International B Biomed Res Int. 2022; 2022:9854346.
PMID: 36531649 PMC: 9750764. DOI: 10.1155/2022/9854346.
Cecilio P, Perez-Cabezas B, Fernandez L, Moreno J, Carrillo E, Requena J PLoS Negl Trop Dis. 2017; 11(11):e0005951.
PMID: 29176865 PMC: 5720812. DOI: 10.1371/journal.pntd.0005951.
Markikou-Ouni W, Drini S, Bahi-Jaber N, Chenik M, Meddeb-Garnaoui A PLoS One. 2015; 10(11):e0143063.
PMID: 26581100 PMC: 4651425. DOI: 10.1371/journal.pone.0143063.